Actively Recruiting
Multicenter Retrospective Cohort Study on Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients
Led by University Hospital, Strasbourg, France · Updated on 2024-07-12
100
Participants Needed
1
Research Sites
1 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Invasive filamentous fungal infections such as aspergillosis, scedosporiosis, mucormycosis, and fusarium wilt are serious complications in immunocompromised patients, especially those who have undergone organ transplants. This research aims to gather recent information on the incidence, risk factors, and outcomes of these infections specifically in heart transplant patients, as current data is limited in this group. This study is an observational retrospective analysis involving adult heart transplant patients who developed invasive fungal infections caused by filamentous fungi from January 1, 2008, to December 31, 2022. It focuses on infections proven or probable by established criteria, including invasive aspergillosis, mucormycosis, fusarium wilt, scedosporiosis, and other similar infections. Participants' medical data will be reviewed to identify how often these infections occur, what risk factors contribute to them, and their prognostic outcomes over a period of up to two years. The study does not involve treatment but collects clinical information to improve understanding and management of these infections in heart transplant patients. All data use is subject to patient consent regarding data reuse for research purposes.
CONDITIONS
Brief Title
Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patient 18 years old or older
- Heart transplant recipient
- Documented invasive fungal infection with filamentous fungi between January 1, 2008 and December 31, 2022
- Proven or probable infection with filamentous fungi including invasive aspergillosis, mucormycosis, fusarium wilt, scedosporiosis, or other filamentous fungus infection based on EORTC/MSGERC criteria
- No opposition expressed by the patient to reuse of their data for research purposes
You will not qualify if you...
- Patient who has expressed opposition to participating in the study
- Patient who has not undergone a liver transplant
- Patient under guardianship, curatorship, or legal protection measures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 2 years
Participants who have undergone heart transplant and experienced invasive fungal infections are observed through review of their medical records.
Trial Site Locations
Total: 1 location
1
Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France
Strasbourg, France, 67091
Actively Recruiting
Research Team
F
François DANION, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here